StevenDanielGreenMD

Oncology • Buffalo, NY

Hematologic Oncology

Assistant Professor of Oncology, Roswell Park Comprehensive Cancer Center

Join to view full profile

Dr. Green is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Green's full profile

Already have an account?

Office
Carlton St & Elm St
Buffalo, NY 14263
Phone+1 716-845-7110
Is this information wrong?

Education & Training

Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2018 - 2021
Indiana University School of MedicineResidency, Internal Medicine, 2015 - 2018
Indiana University School of MedicineClass of 2015, MD
Indiana UniversityBS, Biotechnology, 2007 - 2011

Certifications & Licensure

NY State Medical License 2021 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old Start of enrollment: 2021 Jul 29
Recruiting
Phase 2
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

1 citations
Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia.
Hassan Awada, Mina Abdelmalek, Tara Cronin, Jeffrey Baron, Zakariya Kashour, Farhan Azad, Muhammad Salman Faisal, Mark Faber, Matthew Gravina, Pamela J Sung, Steven D ...> ;Blood Cancer Journal. 2023 Sep 4
TP53 or Not TP53: That Is the Question.
Steven D Green, Joshua F Zeidner> ;Clinical Cancer Research. 2022 Dec 15
6 citations
Engineering Tools for Regulating Hypoxia in Tumour Models.
Steven D Green, Chien-Chi Lin, Heiko Konig> ;Journal of Cellular and Molecular Medicine. 2021 Jul 2
CD123-targeted therapy in acute myeloid leukemia.
Espinoza-Gutarra MR, Green SD, Zeidner JF, Konig H> ;Expert review of hematology. 2021-06-14
6 citations
Secondary AML Emerging After Therapy with Hypomethylating Agents: Outcomes, Prognostic Factors, and Treatment Options.
Daniel R. Richardson, Steven D. Green, Matthew C. Foster, Joshua F. Zeidner> ;Current Hematologic Malignancy Reports. 2021 Feb 1
Clinical conundrum: managing iron overload after renal transplantation.
Upadhyay B, Green SD, Khanal N, Antony AC> ;BMJ case reports. 2021-02-05
Management of fever and neutropenia in the adult patient with acute myeloid leukemia.
Peseski AM, McClean M, Green SD, Beeler C, Konig H> ;Expert review of anti-infective therapy. 2020-10-05
18 citations
Treatment of Acute Myeloid Leukemia in the Era of Genomics-Achievements and Persisting Challenges.
Steven D. Green, Heiko Konig> ;Frontiers in Genetics. 2020 May 27
51 citations
Coming to grips with complex disorders: genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomics.
S D Patel, Helen Le-Niculescu, Daniel L. Koller, S. D. Green, Debomoy K. Lahiri, Francis J. McMahon, John I. Nurnberger, Alexander B. Niculescu> ;American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 2010 Jun 1
Join now to see all

Hospital Affiliations

Roswell Park Comprehensive Cancer CenterBuffalo, New York
Eskenazi HealthIndianapolis, Indiana